首页> 外文期刊>Cell biochemistry and biophysics >Evaluation of the Etoricoxib-Mediated Pain-Relieving Effect in Patients Undergoing Lumbar Fusion Procedures for Degenerative Lumbar Scoliosis: A Prospective Randomized, Double-Blind Controlled Study
【24h】

Evaluation of the Etoricoxib-Mediated Pain-Relieving Effect in Patients Undergoing Lumbar Fusion Procedures for Degenerative Lumbar Scoliosis: A Prospective Randomized, Double-Blind Controlled Study

机译:进行退行性腰椎侧弯腰椎融合术的患者接受依托考昔介导的疼痛缓解效果的评估:一项前瞻性随机双盲对照研究

获取原文
获取原文并翻译 | 示例
           

摘要

This randomized, double-blind study was carried out to evaluate the effectiveness of etoricoxib in controlling the pain during lumbar fusion surgery of the degenerative lumbar scoliosis patients. We found that perioperative use of etoricoxib produced a significant reduction in the degree of pain compared to the patients treated with placebo. Etoricoxib eased the pain and helped to manage the discomfort of lumbar fusion surgery. In addition, etoricoxib was well tolerated as it caused no serious adverse reaction, suggesting a safe profile. Etoricoxib also appeared to ensure and promote the positive effect of surgery, however, insignificantly. Thus, the results suggest that etoricoxib was effective in safely managing the pain during the lumbar fusion surgery and recovery thereafter.
机译:这项随机,双盲研究旨在评估依托昔布在退行性腰椎侧弯患者腰椎融合手术中控制疼痛的有效性。我们发现,与安慰剂治疗的患者相比,围手术期使用依托考昔可显着减轻疼痛程度。依托昔布缓解了疼痛,并帮助控制了腰椎融合手术的不适感。此外,依托昔布没有引起严重的不良反应,因此耐受性良好,表明安全。依托昔布也似乎可以确保并促进手术的积极作用,但是,这无关紧要。因此,结果表明依托考昔可有效地安全治疗腰椎融合手术中的疼痛并在此后恢复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号